Odyssey Therapeutics, Inc. (ODTX) vs SpyGlass Pharma, Inc. Common Stock (SGP)
A side-by-side comparison of Odyssey Therapeutics, Inc. and SpyGlass Pharma, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ODTX
Odyssey Therapeutics, Inc.
$18.13HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SGP
SpyGlass Pharma, Inc. Common Stock
$25.13HealthcareDelayed quote: Oct 6, 2026, 3:55 PM EDT
Total return — ODTX vs SGP
growth of $100 · dividends reinvested · last 1yODTX +26.9% (+26.9%/yr)SGP +9.3% (+9.3%/yr)ODTX compounded faster over this window
ODTX SGP
ODTX vs SGP: by the numbers
- •ODTX is the larger company ($871M vs $840M market cap).
- •Both run net losses; SGP's is the smaller (0.00% vs -4994.86% net margin).
Metrics side by side
Valuation
| Metric | ODTX | SGP |
|---|---|---|
| P/B ratio | 2.07 | 3.62 |
Profitability
| Metric | ODTX | SGP |
|---|---|---|
| Gross margin | 100.00% | 0.00% |
| Operating margin | -5415.19% | 0.00% |
| Net margin | -4994.86% | 0.00% |
| ROE | N/A | -24.12% |
| ROIC | -66.23% | -26.54% |
Go deeper
Dig into the metrics
Odyssey Therapeutics ROESpyGlass Pharma, Inc. Common Stock ROEOdyssey Therapeutics operating marginSpyGlass Pharma, Inc. Common Stock operating marginOdyssey Therapeutics revenue growthSpyGlass Pharma, Inc. Common Stock revenue growthOdyssey Therapeutics free cash flowSpyGlass Pharma, Inc. Common Stock free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.